The role of fibrin glue instillation under skin flaps in the prevention of seroma formation and related morbidities following breast and axillary surgery for breast cancer: A meta-analysis

Journal of Surgical Oncology

Volumn 106, Issue 6, 2012, Pages 783-795

  Sajid, Muhammad S ^a   Hutson, Kristian ^a   Kalra, Lorain ^a   Bonomi, Riccardo ^a  

^a WORTHING HOSPITAL   (United Kingdom)

Author keywords

axillary dissection; breast cancer; fibrin glue; mastectomy; seroma

Indexed keywords

FIBRIN GLUE;

AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER SURGERY; DRUG INSTILLATION; HUMAN; LENGTH OF STAY; LYMPH NODE DISSECTION; META ANALYSIS; MORBIDITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SEROMA; SKIN FLAP; SURGICAL INFECTION; SYSTEMATIC REVIEW; TUMOR VOLUME; WOUND INFECTION;

AXILLA; BREAST NEOPLASMS; DRAINAGE; FEMALE; FIBRIN TISSUE ADHESIVE; HUMANS; LENGTH OF STAY; MORBIDITY; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROMA; SURGICAL FLAPS; SURGICAL WOUND INFECTION;

EID: 84867872275     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23140     Document Type: Review

References (72)

1. Kram HB, Nathan RC, Stafford FJ, et al.: Fibrin glue achieves haemostasis in patients with coagulation disorders. Arch Surg 1989; 124: 385-387.
2. Modi P, Rahamim J:, Fibrin sealant treatment of splenic injuries during oesophagectomy. Eur J Cardiothorac Surg 2005; 28: 167-168.
3. Franceschi D, Madsen T, Weatherford C, et al.: A multicenter randomized clinical trial using fibrin sealant, produced by the Cryoseal FS system in patients undergoing liver resection. Transfus Altern Transfus Med 2006; 8: 92.
4. Briceño J, Naranjo A, Ciria R, et al.: A prospective study of the efficacy of clinical application of a new carrier-bound fibrin sealant after liver resection. Arch Surg 2010; 145: 482-488.
5. Brieler HS, Birker T, Elfeld H, et al.: Effectiveness of various methods of stopping hemorrhage in spleen and liver injuriesâResults of an animal experiment study. Z Exp Chir Transplant Kunstliche Organe 1986; 19: 94-99.
6. Sierra DH:, Fibrin sealant adhesive systems: A review of their chemistry, material properties and clinical applications. J Biomater Appl 1993; 7: 309-352.
7. EroÄlu E, Oral S, Unal E, et al.: Reducing seroma formation with fibrin glue in an animal mastectomy model. Eur J Surg Oncol 1996; 22: 137-139.
8. Rousou JA, Engleman RM, Breyer RH:, Fibrin glue: An effective homeostatic agent for non-suturable intraoperative bleeding. Ann Thorac Surg 1984; 38: 409.
9. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). http://www.cochrane- handbook.org [accessed 15th December 2011].
10. Review Manager (RevMan) [Computer program]. Version 5.0. The Nordic Cochrane Centre, The Cochrane Collaboration: Copenhagen, 2008.
11. DerSimonian R, Laird N:, Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
12. DeMets DL:, Methods for combining randomized clinical trials: Strengths and limitations. Stat Med 1987; 6: 341-350.
13. Higgins JP, Thompson SG:, Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
14. Egger M, Smith GD, Altman DG:, Systematic reviews in healthcare. London: BMJ Publishing; 2006.
15. Deeks JJ, Altman DG, Bradburn MJ:, Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In:, Egger M, Smith GD, Altman GD, editors. Systemic reviews in health care: Meta-analysis in context, 2nd edition. London: BMJ Publication Group; 2001. pp 285-312.
16. Jadad AR, Moore RA, Carroll D, et al.: Assessing the quality of reports of randomized clinical trials: Is blinding necessary ? Control Clin Trials 1996; 17: 1-12.
17. Chalmers TC, Smith H, Jr., Blackburn B, et al.: A method for assessing the quality of a randomized control trial. Control Clin Trials 1981; 2: 31-49.
18. Cochrane IMS: http://ims.cochrane.org/revman/otherresources/gradepro/ download [accessed on 15 December 2011 ].
19. Cipolla C, Fricano S, Vieni S, et al.: Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. J Surg Oncol 2010; 101: 600-603.
20. Dinsmore RC, Harris JA, Gustafson RJ:, Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: A prospective randomized trial. Am Surg 2000; 66: 982-985.
21. El Nakeeb A:, Influence of fibrin glue on seroma formation after modified radical mastectomy: A prospective randomized study. Breast J 2009; 15: 671-672.
22. Gilly FN, François Y, Sayag-Beaujard AC, et al.: Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: Prospective randomized trial. Eur Surg Res 1998; 30: 439-443.
23. Gioffrè Florio MA, Mezzasalma F, Manganaro T, et al.: The use of fibrin glue in the surgery of breast carcinoma. G Chir 1993; 14: 239-241.
24. Jain PK, Sowdi R, Anderson AD, et al.: Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. Br J Surg 2004; 91: 54-60.
25. Johnson L, Cusick TE, Helmer SD, et al.: Influence of fibrin glue on seroma formation after breast surgery. Am J Surg 2005; 189: 319-323.
26. Ko E, Han W, Cho J, et al.: Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: A prospective randomized trial. J Korean Med Sci 2009; 24: 92-96.
27. Langer S, Guenther JM, DiFronzo LA:, Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer ? Am Surg 2003; 69: 77-81.
28. Moore MM, Nguyen DH, Spotnitz WD:, Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: A randomized prospective trial. Am Surg 1997; 63: 97-102.
29. Moore M, Burak WE, Jr., Nelson E, et al.: Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: A randomized prospective clinical trial. J Am Coll Surg 2001; 192: 591-599.
30. Mustonen PK, Härmä MA, Eskelinen MJ:, The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scand J Surg 2004; 93: 209-212.
31. Ruggiero R, Procaccini E, Gili S, et al.: New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. G Chir 2009; 30: 306-310.
32. Segura-Castillo JL, Estrada-Rivera O, Castro-Cervantes JM, et al.: Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cir Cir 2005; 73: 345-350.
33. Tasinato R, Godina M, Griggio L, et al.: Prevention of axillary seromas in patients who underwent lymphadenectomy for breast cancer. Acta Chir It 1993; 49: 479-484.
34. Udén P, Aspegren K, Balldin G, et al.: Fibrin adhesive in radical mastectomy. Eur J Surg 1993; 159: 263-265.
35. Ulusoy AN, Polat C, Alvur M, et al.: Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: A prospective randomized study. Breast J 2003; 9: 393-396.
36. Vaxman F, Kolbe A, Stricher F, et al.: Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. Eur Surg Res 1995; 27: 346-352.
37. Cancer facts sheet No. 297 [Computer program]. World Health Organization. New York, USA: WHO, 2011. http://www.who.int/mediacentre/factsheets/fs297/en/ [Accessed on 4 March 2012].
38. de Lorenzi F:, Oncoplastic surgery: The evolution of breast cancer treatment. Breast J 2010; 16: S20-S21.
39. Denewer A, Farouk O, Mostafa W, et al.: Social support and hope among Egyptian women with breast cancer after mastectomy. Breast Cancer (Auckl) 2011; 5: 93-103.
40. Krekel NM, Zonderhuis BM, Schreurs HW, et al.: Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life. A prospective multicentre randomised controlled clinical trial comparing ultrasound-guided surgery to traditional palpation-guided surgery (COBALT trial). BMC Surg 2011; 11: 8.
41. Loukas M, Tubbs RS, Mirzayan N, et al.: The history of mastectomy. Am Surg 2011; 77: 566-571.
42. Sakorafas GH, Safioleas M:, Breast cancer surgery: An historical narrative. Part III. From the sunset of the 19th to the dawn of the 21st century. Eur J Cancer Care (England) 2010; 19: 145-166.
43. Saratzis A, Soumian S, Willetts R, et al.: Use of multiple drains after mastectomy is associated with more patient discomfort and longer postoperative stay. Clin Breast Cancer 2009; 9: 243-246.
44. Gong Y, Xu J, Shao J, et al.: Prevention of seroma formation after mastectomy and axillary dissection by lymph vessel ligation and dead space closure: A randomized trial. Am J Surg 2010; 200: 352-356.
45. Braithwaite D, Satariano WA, Sternfeld B, et al.: Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst 2010; 102: 1468-1477.
46. Pinnarà P, Rambone R, Giordano C, et al.: Long-term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. Am J Clin Oncol 2011; 34: 238-244.
47. Woodworth PA, Mcboyle MF, Helmer SD, et al.: Seroma formation after breast cancer surgery: Incidence and predicting factors. Am Surg 2000; 66: 444-450.
48. Kuroi K, Shimozuma K, Taguchi T, et al.: Pathophysiology of seroma in breast cancer. Breast Cancer 2005; 12: 288-293.
49. Burak WE, Jr., Goodman PS, Young DC, et al.: Seroma formation following axillary dissection for breast cancer: Risk factors and lack of influence of bovine thrombin. J Surg Oncol 1997; 64: 27-31.
50. Kumar S, Lal B, Misra MC:, Post-mastectomy seroma: A new look into the aetiology of an old problem. J R Coll Surg Edinb 1995; 40: 292-294.
51. Tadych K, Donegan WL:, Postmastectomy seromas and wound drainage. Surg Gynecol Obstet 1987; 165: 483-487.
52. McCaul JA, Aslaam A, Spooner RJ, et al.: Aeitology of seroma formation in patients undergoing surgery for breast cancer. Breast 2000; 9: 144-148.
53. Corion LU, Smeulders MJ, van Zuijlen PP, et al.: Draining after breast reduction: A randomised controlled inter-patient study. J Plast Reconstr Aesthet Surg 2009; 62: 865-868.
54. Chintamani, Singhal V, Singh J, et al.: Half versus full vacuum suction drainage after modified radical mastectomy for breast cancerâA prospective randomized clinical trial. BMC Cancer 2005; 5: 11.
55. Divino CM, Kuerer HM, Tartter PI:, Drains prevent seromas following lumpectomy with axillary dissection. Breast J 2000; 6: 31-33.
56. Puttawibul P, Sangthong B, Maipang T, et al.: Mastectomy without drain at pectoral area: A randomized controlled trial. J Med Assoc Thailand 2003; 86: 325-331.
57. Gupta R, Pate K, Varshney S, et al.: A comparison of 5-day and 8-day drainage following mastectomy and axillary. Eur J Surg Oncol 2001; 27: 26-30.
58. Petrek JA, Peters MM, Cirrincione C, et al.: A prospective randomized trial of single versus multiple drains in the axilla after lymphadenectomy. Surg Gynecol Obstet 1992; 175: 405-409.
59. Terrell GS, Singer JA:, Axillary versus combined axillary and pectoral drainage after modified radical mastectomy. Surg Gynecol Obstet 1992; 175: 437-440.
60. Bourke JB, Balfour TW, Hardcastle JD, et al.: A comparison between suction and corrugated drainage after simple mastectomy: A report of a controlled trial. Br J Surg 1976; 63: 67-69.
61. Dancey AL, Cheema M, Thomas SS:, A prospective randomized trial of the efficacy of marginal quilting sutures and fibrin sealant in reducing the incidence of seromas in the extended latissimus dorsi donor site. Plastic Reconstr Surg 2010; 125: 1309-1317.
62. O'Hea BJ, Ho MN, Petrek JA:, External compression dressing versus standard dressing after axillary lymphadenectomy. Am J Surg 1999; 177: 450-453.
63. Kozomara D, GaliÄ G, Brekalo Z, et al.: A randomised two-way comparison of mastectomy performed using harmonic scalpel or monopolar diathermy. Coll Antropol 2010; 34: 105-112.
64. Galatius H, Okholm M, Hoffmann J:, Mastectomy using ultrasonic dissection: Effect on seroma formation. Breast 2003; 12: 338-341.
65. Chen CM, Cano SJ, Klassen AF, et al.: Measuring quality of life in oncologic breast surgery: A systematic review of patient-reported outcome measures. Breast J 2010; 16: 587-597.
66. Rice DC, Morris SM, Sarr MG, et al.: Intraoperative topical tetracycline sclerotherapy following mastectomy: A prospective, randomized trial. J Surg Oncol 2000; 73: 224-227.
67. Coons MS, Folliguet TA, Rodriguez C, et al.: Prevention of seroma formation after dissection of musculocutaneous flaps. Am Surg 1993; 59: 215-218.
68. Taflampas P, Sanidas E, Christodoulakis M, et al.: Sealants after axillary lymph node dissection for breast cancer: Good intentions but bad results. Am J Surg 2009; 198: 55-58.
69. Hidar S, Soussi K, Bibi M, et al.: Influence of ketoprofen on drainage volume after radical breast cancer surgery: A prospective randomized clinical trial. J Turkish German Gynecol Assoc 2007; 8: 71-75.
70. Berger A, Tempfer C, Hartmann B, et al.: Sealing of postoperative axillary leakage after axillary lymphadenectomy using a fibrin glue coated collagen patch: A prospective randomised study. Breast Cancer Res Treat 2001; 67: 9-14.
71. Carless PA, Henry DA:, Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery. Br J Surg 2006; 93: 810-819.
72. Ruggiero R, Procaccini E, Piazza P, et al.: Effectiveness of fibrin glue in conjunction with collagen patches to reduce seroma formation after axillary lymphadenectomy for breast cancer. Am J Surg 2008; 196: 170-174.